
Sygnature Discovery, an integrated drug discovery contract research organisation (CRO), has announced the appointment of Susanne Back as Head of …
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia

